William J. Newell
Chief Executive Officer, Sutro Biopharma, Inc.
Bill Newell joined Sutro Biopharma as CEO in January 2009. Previously, he served as the President of Aerovance, Inc., a venture-backed company developing clinical assets for respiratory diseases. Mr. Newell also was Chief Business Officer and Senior Vice President at publicly-traded QLT, Inc. and served in several senior management positions at public-traded Axys Pharmaceuticals, Inc. For the 16 years prior to joining Axys, Mr. Newell practiced corporate law in the San Francisco Bay Area. He is presently a member of the Boards at SutroVax and at Symic Bio. Mr. Newell is presently Chair of the Board of the California Life Sciences Association and a member of the Governing Board of the Emerging Companies Section of the Biotechnology Innovation Organization (BIO).